Medicare Enrolled
Dr. Larry Neuman
Family Medicine · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Neuman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Neuman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Neuman
Dr. Larry Neuman is a family medicine specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Neuman performed 7,013 Medicare services across 2,300 unique beneficiaries.
Between the years covered by Open Payments, Dr. Neuman received a total of $375,498 from 80 pharmaceutical and/or device companies across 1992 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Neuman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in NY
$375,498 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,013
Medicare services
Top 2% in NY for family medicine
2,300
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~369 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,714 | $57 | $100 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,497 | $45 | $75 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,365 | $48 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,272 | $56 | $140 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
388 | $31 | $89 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
250 | $148 | $296 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
81 | $110 | $200 |
| Flexible laryngoscopy A diagnostic exam of the voice box using a flexible endoscope to visualize the larynx. |
69 | $112 | $296 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
46 | $4 | $50 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
46 | $111 | $271 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $13 | $50 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
40 | $180 | $400 |
| Denosumab injection (Prolia/Xgeva) | 40 | $0 | $0 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
38 | $29 | $50 |
| Annual depression screening | 36 | $21 | $50 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
30 | $38 | $97 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $81 | $216 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
17 | $57 | $150 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
16 | $30 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$375,498
Total received (2018-2024)
Avg $53,643/year across 7 years
Top 0% in NY for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,992
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$324,000 (86.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,753 (7.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$24,744 (6.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$63,131
2023
$70,738
2022
$59,639
2021
$41,606
2020
$53,007
2019
$52,498
2018
$34,878
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Axsome Therapeutics, Inc.
$21,907
ABBVIE INC.
$18,703
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$13,401
Intra-Sana Laboratories
$3,661
CMP Pharma, Inc.
$1,250
AstraZeneca Pharmaceuticals LP
$779
Ardelyx, Inc.
$617
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$459
Sumitomo Pharma America, Inc.
$284
Amgen Inc.
$227
Exact Sciences Corporation
$205
PFIZER INC.
$189
IDORSIA PHARMACEUTICALS US INC
$165
CeQur Corporation
$164
Novo Nordisk Inc
$163
Paratek Pharmaceuticals, Inc.
$161
SCPHARMACEUTICALS INC.
$140
ViiV Healthcare Company
$94
Azurity Pharmaceuticals, Inc.
$79
Lilly USA, LLC
$70
Esperion Therapeutics, Inc.
$63
Lundbeck LLC
$61
Teva Pharmaceuticals USA, Inc.
$54
Gilead Sciences, Inc.
$42
Dexcom, Inc.
$31
Bayer Healthcare Pharmaceuticals Inc.
$29
Novartis Pharmaceuticals Corporation
$27
Kowa Pharmaceuticals America, Inc.
$22
GlaxoSmithKline, LLC.
$22
Optinose US, Inc.
$16
AGEPHA Pharma FZ LLC
$16
AIMMUNE THERAPEUTICS, INC.
$15
Xeris Pharmaceuticals, Inc.
$14
Top 3 companies account for 85.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$94,827
Gilead Sciences, Inc.
$45,283
Allergan, Inc.
$39,828
AbbVie Inc.
$34,648
CMP Pharma, Inc.
$27,015
Axsome Therapeutics, Inc.
$22,225
AbbVie, Inc.
$15,695
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$13,401
Allergan Inc.
$12,794
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$8,691
Synergy Pharmaceuticals Inc
$8,571
Esperion Therapeutics, Inc.
$6,227
ITI, Inc.
$5,918
AstraZeneca Pharmaceuticals LP
$5,550
Sumitomo Pharma America, Inc.
$5,250
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,030
Intra-Sana Laboratories
$3,678
Biohaven Pharmaceuticals, Inc.
$2,220
GlaxoSmithKline, LLC.
$1,485
Sunovion Pharmaceuticals Inc.
$1,342
SANOFI-AVENTIS U.S. LLC
$1,043
Janssen Pharmaceuticals, Inc
$912
UROVANT SCIENCES INC
$890
Amgen Inc.
$843
Novo Nordisk Inc
$781
Lilly USA, LLC
$695
PFIZER INC.
$690
Janssen Products, LP
$654
Ardelyx, Inc.
$617
Janssen Biotech, Inc.
$584
Regeneron Healthcare Solutions, Inc.
$515
Biohaven Pharmaceutical Holding Company Ltd.
$507
Avanir Pharmaceuticals, Inc.
$459
Horizon Pharma plc
$456
Amarin Pharma Inc.
$444
Exact Sciences Corporation
$433
BioCryst US Sales Co., LLC
$418
Merck Sharp & Dohme Corporation
$395
UCB, Inc.
$391
Alkermes, Inc.
$372
Otsuka America Pharmaceutical, Inc.
$328
Bayer HealthCare Pharmaceuticals Inc.
$280
Genentech USA, Inc.
$273
Intuity Medical Inc
$268
Horizon Therapeutics plc
$245
Nestle HealthCare Nutrition Inc.
$234
IDORSIA PHARMACEUTICALS US INC
$216
Mannkind Corporation
$198
Mylan Specialty L.P.
$190
Novartis Pharmaceuticals Corporation
$187
MannKind Corporation
$174
CeQur Corporation
$164
Xeris Pharmaceuticals, Inc.
$162
Paratek Pharmaceuticals, Inc.
$161
SCPHARMACEUTICALS INC.
$140
Scilex Pharmaceuticals Inc.
$135
ARALEZ PHARMACEUTICALS US INC.
$125
Janssen Scientific Affairs, LLC
$122
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$114
Astellas Pharma US Inc
$111
Biogen, Inc.
$110
Lundbeck LLC
$108
ViiV Healthcare Company
$94
Azurity Pharmaceuticals, Inc.
$79
Corcept Therapeutics
$76
Bayer Healthcare Pharmaceuticals Inc.
$66
Teva Pharmaceuticals USA, Inc.
$54
Ironwood Pharmaceuticals, Inc
$52
Kowa Pharmaceuticals America, Inc.
$50
E.R. Squibb & Sons, L.L.C.
$35
Dexcom, Inc.
$31
BioCryst Pharmaceuticals, Inc.
$18
Mission Pharmacal Company
$17
Optinose US, Inc.
$16
AGEPHA Pharma FZ LLC
$16
Takeda Pharmaceuticals U.S.A., Inc.
$15
SCILEX PHARMACEUTICALS INC.
$15
IBSA Pharma Inc.
$15
Shire North American Group Inc
$15
AIMMUNE THERAPEUTICS, INC.
$15
Top 3 companies account for 47.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AFREZZA · AIRSUPRA · AJOVY · ANORO · APRETUDE · ARISTADA · Aimovig · Atorvaliq · Austedo XR · Auvelity · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Biktarvy · CAPLYTA · CAROSPIR · CHANTIX · COLOGUARD · COMIRNATY · CREON · CYCLOSET · CaroSpir · Carospir · CeQur Simplicity · Cologuard Collection Kit · Creon · DOVATO · Descovy · Dexcom G6 Transmitter · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Epclusa · FARXIGA · FASENRA · FUROSCIX · Ferralet 90 · GEMTESA · GLASSIA · GLYCATE · IBSRELA · INVOKANA · ISENTRESS · JANUVIA · JARDIANCE · KEVEYIS · KRYSTEXXA · Kerendia · Korlym · LATUDA · LEQVIO · LICART · LINZESS · LODOCO · LONHALA MAGNAIR · LUCEMYRA · LYBALVI · LYRICA · LifeVest · Linzess · Liqrev · Livalo · MOUNJARO · MULTAQ · MYRBETRIQ · Mavyret · Myrbetriq · NEXLETOL · NEXLIZET · NO_PRODUCT · NUCALA · NUEDEXTA · NURTEC ODT · NUZYRA · Neupro · Norliqva · ORLADEYO · Orladeyo · Otezla · Ozempic · PENNSAID · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREZCOBIX · Pogo Automatic Blood Glucose Monitoring System · Prolia · QULIPTA · QUVIVIQ · RAYOS · RECORLEV · RELISTOR · RELTONE 200 MG · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYMTUZA · Saxenda · Symtuza · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · Tadliq · Tresiba · Trulance · Truvada · UBRELVY · VIBERZI · VIIBRYD · VIMOVO · VRAYLAR · Vascepa · XARELTO · XIFAXAN · XIFIXAN · Xhance · Xofluza · Xolair · YUPELRI · Yupelri · ZAVZPRET · ZENPEP · ZONTIVITY · ZORYVE · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for family medicine in NY.
Geographic Context
Family medicine physicians within 10 mi
3,235
Per 100K population
198.7
County median income
$104,553
Nearest hospital
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Neuman is a clinical cardiology specialist, with above-average Medicare volume (top 2% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Neuman experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Neuman performed 1,714 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Neuman receive payments from pharmaceutical companies?
Yes. Dr. Neuman received a total of $375,498 from 80 companies across 1,992 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Neuman's costs compare to other family medicine physicians in New York?
Dr. Neuman's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Neuman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in New York
Browse family medicine physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NY
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NY
Which NY family medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology